Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  US Nuclear Corp.    UCLE

US NUCLEAR CORP.

(UCLE)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

US Nuclear Corp. Reports 172% Increase in Revenue in Second Quarter 2019 Results

09/09/2019 | 08:31am EST

LOS ANGELES, CA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- US Nuclear Corp. (OTC: UCLE) 

  • Sales for the three months ended June 30, 2019 were $1,530,523, an increase of $968,995 or 172% as compared to the same period in 2018
  • Gross profit was $785,933 compared to $287,799 for the same period in 2018, an increase of 173%
  • Cash increased from $969,118 to $1,393,915 for the six months ended June 30, 2019
  • Stock based compensation was $804,131 compared to $328,320 during the same period in 2018
  • Net loss from operations ($466,019) due to stock-based compensation as the company acquires new partnerships, technology, sales and marketing consultants, and other services to facilitate company growth

US Nuclear Corp., a leading manufacturer and seller of advanced radiation and chemical detection instrumentation, recently announced the financial results for the second quarter ended June 30, 2019.  

“We had a very successful and productive second quarter in 2019.  Key metrics are increasing, with sales revenue up 172% from the same period last year,” commented Robert I. Goldstein, President, CEO, and Chairman of US Nuclear Corp. “Leaving out the stock-based compensation, our business operation had a dollar profit of $338,112, which is the main reason for the cash increase of $424,797. The increase in sales revenue can be attributed to strong sales growth of our signature products, including: air quality monitors, tritium monitors, and forensic drones. Being first to market with our scientific drones allowed us to establish ourselves at the forefront of this fast-growing industry and we look forward to capitalizing on our momentum.”  

US Nuclear Corp. also recently teamed up with QYSEA Technology to design and build new ‘DiveRAD’ product line, industrial underwater robots integrated with radiological, chemical, biological, and video sensors to monitor and protect the world’s vital water sources and marine life, such as reservoirs, seaports, around nuclear power plants, and environmentally sensitive areas.  

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com

CONTACT:
US Nuclear Corp. (OTC: UCLE)
Robert I. Goldstein, President, CEO, and Chairman 
Rachel Boulds, Chief Financial Officer
(818) 883 7043

Primary Logo


© GlobeNewswire 2019
All news about US NUCLEAR CORP.
01/06US NUCLEAR CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/06US NUCLEAR : 2019 Convertible Debenture Now Fully Converted, Closed, and Flat
AQ
2020US Nuclear Corp. Discusses The Progress of Its MIFTEC Contract and Overhuff T..
NE
2020US Nuclear Corp. Announces Third Quarter 2020 Results
GL
2020US NUCLEAR : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020US NUCLEAR : and Grapheton Brain Implants to Help Immobilized Patients
AQ
2020US Nuclear and Grapheton Brain Implants to Help Immobilized Patients
GL
2020US NUCLEAR : Secures Its Position at Bioelectronics Startup Grapheton
AQ
2020US Nuclear Secures Its Position at Bioelectronics Startup Grapheton
GL
2020US NUCLEAR : Tritium Monitor Market Soars Due to Construction of $20+ Billion IT..
AQ
More news
Financials (USD)
Sales 2019 3,54 M - -
Net income 2019 -3,16 M - -
Net cash 2019 0,10 M - -
P/E ratio 2019 -4,28x
Yield 2019 -
Capitalization 7,41 M 7,41 M -
EV / Sales 2018 2,02x
EV / Sales 2019 3,85x
Nbr of Employees 20
Free-Float 48,4%
Chart US NUCLEAR CORP.
Duration : Period :
US Nuclear Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Robert I. Goldstein Chairman, President & Chief Executive Officer
Richard Landry COO & Director-Investor Relations
Rachel Boulds Chief Financial Officer & Secretary
Michael G. Hastings Director
Dell Williamson Director
Sector and Competitors